Product Information
- (2S)-2-(tert-Butoxycarbonylamino)-5-[(N-nitrocarbamimidoyl)amino]pentanoic acid
- (2S)-2-[[(tert-Butoxy)carbonyl]amino]-5-(N′-nitrocarbamimidamido)pentanoic acid
- (2S)-5-[Amino(nitramido)methylidene]azaniumyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
- <span class="text-smallcaps">L</span>-Ornithine, N<sup>2</sup>-[(1,1-dimethylethoxy)carbonyl]-N<sup>5</sup>-[imino(nitroamino)methyl]-
- Boc-Arg(NO2)-OH
- Boc-Arg(No2)
- Boc-L-nitroarginine
- N-Boc-N'-nitro-L-arginine
- N<sup>2</sup>-[(1,1-Dimethylethoxy)carbonyl]-N<sup>5</sup>-[imino(nitroamino)methyl]-<span class="text-smallcaps">L</span>-ornithine
- N<sup>2</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitroarginine
- See more synonyms
- N<sup>2</sup>-tert-Butyloxycarbonyl-N<sup>ω</sup>-nitro-<span class="text-smallcaps">L</span>-arginine
- N<sup>α</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitro-<span class="text-smallcaps">L</span>-arginine
- N<sup>α</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitroarginine
- Ornithine, N<sup>2</sup>-carboxy-N<sup>5</sup>-(nitroamidino)-, N-tert-butyl ester
- Ornithine, N<sup>2</sup>-carboxy-N<sup>5</sup>-(nitroamidino)-, N<sup>2</sup>-tert-butyl ester, <span class="text-smallcaps">L</span>-
- Nα-tert-Butoxycarbonyl-NG-nitro-L-arginine
- Ornithine, N2-carboxy-N5-(nitroamidino)-, N-tert-butyl ester
- N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-L-ornithine
- L-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-
- Ornithine, N2-carboxy-N5-(nitroamidino)-, N2-tert-butyl ester, L-
Boc-L-Nitroarginine is a nitric oxide synthase inhibitor that belongs to the class of drugs called nitric oxide inhibitors. It is a potent inhibitor of nitric oxide synthase, preventing the production of nitric oxide from arginine. The drug has been shown to have therapeutic effects in the treatment of cancer, diabetes mellitus, and other diseases. Boc-L-Nitroarginine inhibits tumor angiogenesis by blocking endothelial cell proliferation and migration. It also inhibits insulin secretion, leading to an improved glycemic control in diabetic patients. Boc-L-Nitroarginine can be used as a hydrogenation reducing agent for the synthesis of imatinib and palladium catalysts for hydrogenation reactions.
Chemical properties
Technical inquiry about: 3D-FB39246 Boc-L-Nitroarginine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.